Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and ursodeoxycholic acid for post-acute sequelae of SARS-CoV-2 infection (PASC)
KCT0009342Phase 4Completed
- Sponsor
- Ministry of Health & Welfare
- Start
- Jul 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin, ursodeoxycholic acid in post-COVID syndrome, sponsored by Ministry of Health & Welfare. Started Jul 2024; status: completed.
02
Drugs
metforminursodeoxycholic acid
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on KCT0009342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009342.